177 related articles for article (PubMed ID: 9050018)
1. Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine.
Schäfers RF; Poller U; Pönicke K; Geissler M; Daul AE; Michel MC; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):239-49. PubMed ID: 9050018
[TBL] [Abstract][Full Text] [Related]
2. Influence of atropine on the cardiovascular effects of noradrenaline and tyramine in elder volunteers.
Poller U; Schäfers RF; Schmuck S; Jakubetz J; Radke J; Daul AE; Pönicke K; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):100-6. PubMed ID: 9228196
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers.
Daul A; Elter-Schulz M; Poller U; Jockenhövel F; Pönicke K; Boomsma F; Man in't Veld AJ; Schäfes RF; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):429-37. PubMed ID: 8532072
[TBL] [Abstract][Full Text] [Related]
4. The role of alpha 1- and alpha 2-adrenoceptors in the coronary vasoconstrictor responses to neuronally released and exogenous noradrenaline in the dog.
Woodman OL
Naunyn Schmiedebergs Arch Pharmacol; 1987 Aug; 336(2):161-8. PubMed ID: 2891038
[TBL] [Abstract][Full Text] [Related]
5. Modulation of noradrenaline release by peripheral presynaptic alpha 2-adrenoceptors in humans.
Jie K; van Brummelen P; Vermey P; Timmermans PB; van Zwieten PA
J Cardiovasc Pharmacol; 1987 Apr; 9(4):407-13. PubMed ID: 2438503
[TBL] [Abstract][Full Text] [Related]
6. Adrenoceptors mediating the cardiovascular and metabolic effects of alpha-methylnoradrenaline in humans.
Schäfers RF; Nürnberger J; Herrmann B; Wenzel RR; Philipp T; Michel MC
J Pharmacol Exp Ther; 1999 May; 289(2):918-25. PubMed ID: 10215671
[TBL] [Abstract][Full Text] [Related]
7. Terbutaline-induced desensitization of human cardiac beta 2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen.
Poller U; Fuchs B; Gorf A; Jakubetz J; Radke J; Pönicke K; Brodde OE
Cardiovasc Res; 1998 Oct; 40(1):211-22. PubMed ID: 9876334
[TBL] [Abstract][Full Text] [Related]
8. Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta1- and/or beta2-adrenoceptor mediated?
Jakubetz J; Schmuck S; Poller U; Fuchs B; Gorf A; Radke J; Pönicke K; Brodde OE
J Cardiovasc Pharmacol; 1999 Mar; 33(3):461-72. PubMed ID: 10069683
[TBL] [Abstract][Full Text] [Related]
9. Differences between exogenous and endogenous noradrenaline in the effects on vascular post-synaptic alpha 1- and alpha 2-adrenoceptors in man.
Jie K; van Brummelen P; Vermey P; Timmermans PB; van Zwieten PA
J Hypertens Suppl; 1985 Dec; 3(3):S145-7. PubMed ID: 2856814
[TBL] [Abstract][Full Text] [Related]
10. Postsynaptic alpha 1- and alpha 2-adrenoceptors in human blood vessels: interactions with exogenous and endogenous catecholamines.
Jie K; Van Brummelen P; Vermey P; Timmermans PB; Van Zwieten PA
Eur J Clin Invest; 1987 Apr; 17(2):174-81. PubMed ID: 3034621
[TBL] [Abstract][Full Text] [Related]
11. Reserpine induces vascular alpha 2-adrenergic supersensitivity and platelet alpha 2-adrenoceptor up-regulation in dog.
Estan L; Senard JM; Tran MA; Montastruc JL; Berlan M
Br J Pharmacol; 1990 Oct; 101(2):329-36. PubMed ID: 2175232
[TBL] [Abstract][Full Text] [Related]
12. In vivo demonstration of alpha-adrenoceptor-mediated positive inotropy in pithed rats: evidence that noradrenaline does not stimulate myocardial alpha-adrenoceptors.
Broadley KJ; Williamson KL; Roach AG
J Auton Pharmacol; 1999 Feb; 19(1):55-63. PubMed ID: 10385270
[TBL] [Abstract][Full Text] [Related]
13. The acute cardiovascular actions of intravenous thyrotrophin releasing hormone (TRH) in man are mediated by non-catecholaminergic mechanisms.
Bouloux PM; Corsello S; Besser M; Grossman A
Br J Clin Pharmacol; 1996 Aug; 42(2):225-32. PubMed ID: 8864322
[TBL] [Abstract][Full Text] [Related]
14. Hypotensive and hypertensive effects of catecholamines intrathecally injected in anesthetized rats.
del Carmen García M; Enero MA; Celuch SM
J Auton Nerv Syst; 1996 Jun; 59(1-2):17-26. PubMed ID: 8816361
[TBL] [Abstract][Full Text] [Related]
15. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
[TBL] [Abstract][Full Text] [Related]
16. Noradrenaline contracts rat retinal arterioles via stimulation of α(1A)- and α(1D)-adrenoceptors.
Mori A; Hanada M; Sakamoto K; Nakahara T; Ishii K
Eur J Pharmacol; 2011 Dec; 673(1-3):65-9. PubMed ID: 22040923
[TBL] [Abstract][Full Text] [Related]
17. Involvement of alpha1B-adrenoceptors in the positive inotropic effect of endogenous noradrenaline in rabbit myocardium.
Hattori Y; Kanno M
Eur J Pharmacol; 1997 Jun; 329(2-3):165-8. PubMed ID: 9226409
[TBL] [Abstract][Full Text] [Related]
18. Role of beta1-3-adrenoceptors in blood pressure control at rest and during tyramine-induced norepinephrine release in spontaneously hypertensive rats.
Berg T; Piercey BW; Jensen J
Hypertension; 2010 May; 55(5):1224-30. PubMed ID: 20231523
[TBL] [Abstract][Full Text] [Related]
19. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action.
Lenke D; Gries J; Kretzschmar R
Arzneimittelforschung; 1981; 31(9a):1558-65. PubMed ID: 7197970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
